Evidence map›Paper›PMID 40529141›Full record

ArticleFrontiers in medicine2025

Mirizzi syndrome masquerading as gallbladder carcinoma: a case report on diagnostic challenges and multidisciplinary management.

Yu Yang, Yiwei Hou, Li Yi, Hang Zhou, Lihua Tang, Yunxi Fu, Mingzheng Hu, Rongchun Xing

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yu Yang *The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Yiwei Hou *The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Li YiMedical Technology College of Qiqihar Medical College, Qiqihar, China.
Hang ZhouThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Lihua TangThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Yunxi FuMedical Technology College of Qiqihar Medical College, Qiqihar, China.
Mingzheng HuThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Rongchun XingThe First College of Clinical Medical Science, China Three Gorges University, Yichang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mirizzi syndrome is a rare condition that is frequently misdiagnosed as gallbladder cancer due to overlapping clinical and imaging features. This case underscores the diagnostic challenge of differentiating these two conditions and offers insights into managing such complex presentations. Case summary: A 45-year-old female presented with obstructive jaundice and elevated liver enzymes. Imaging studies, including CT, PET-CT, and MRCP, revealed gallbladder wall thickening, bile duct obstruction, and a high suspicion of malignancy. Tumor markers were within normal limits. Intraoperatively, extensive adhesions, gallbladder wall oedema, and bile duct compression consistent with Mirizzi syndrome were identified. A partial cholecystectomy and bile duct exploration with stent placement were performed. Histopathological examination confirmed chronic cholecystitis with inflammation, but no evidence of malignancy. The patient had an uneventful recovery, with complete resolution of her symptoms. Conclusion: Mirizzi syndrome can closely resemble gallbladder cancer, making careful surgical exploration and pathological evaluation essential for accurate diagnosis.

Indexed as

case reportcholangitisgallbladder cancerMirizzi syndromeobstructive jaundice

Identifiers

PMID40529141
PMCPMC12171177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.